US20150265346A9 - Apparatus, method, and system for selectively effecting and/or killing bacteria - Google Patents
Apparatus, method, and system for selectively effecting and/or killing bacteria Download PDFInfo
- Publication number
- US20150265346A9 US20150265346A9 US14/021,631 US201314021631A US2015265346A9 US 20150265346 A9 US20150265346 A9 US 20150265346A9 US 201314021631 A US201314021631 A US 201314021631A US 2015265346 A9 US2015265346 A9 US 2015265346A9
- Authority
- US
- United States
- Prior art keywords
- radiation
- exemplary
- wavelength
- range
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 28
- 230000005855 radiation Effects 0.000 claims abstract description 75
- CRCGQDIFUPCYPU-UHFFFAOYSA-N [Cl].[Kr] Chemical compound [Cl].[Kr] CRCGQDIFUPCYPU-UHFFFAOYSA-N 0.000 claims description 9
- SBBCVCNRQAYGFO-UHFFFAOYSA-N [Br].[Kr] Chemical compound [Br].[Kr] SBBCVCNRQAYGFO-UHFFFAOYSA-N 0.000 claims description 8
- 230000006378 damage Effects 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 3
- 210000005260 human cell Anatomy 0.000 description 37
- 206010052428 Wound Diseases 0.000 description 15
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 230000002070 germicidal effect Effects 0.000 description 14
- 208000031650 Surgical Wound Infection Diseases 0.000 description 13
- 230000004083 survival effect Effects 0.000 description 13
- 238000012545 processing Methods 0.000 description 10
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 230000003902 lesion Effects 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 206010048038 Wound infection Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 5
- 231100000219 mutagenic Toxicity 0.000 description 5
- 230000003505 mutagenic effect Effects 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- 238000001228 spectrum Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 206010036410 Postoperative wound infection Diseases 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 208000002847 Surgical Wound Diseases 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 210000004940 nucleus Anatomy 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000011882 arthroplasty Methods 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 230000000149 penetrating effect Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 230000005180 public health Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 108050006947 CXC Chemokine Proteins 0.000 description 2
- 102000019388 CXC chemokine Human genes 0.000 description 2
- 230000005778 DNA damage Effects 0.000 description 2
- 231100000277 DNA damage Toxicity 0.000 description 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- UPUOLJWYFICKJI-UHFFFAOYSA-N cyclobutane;pyrimidine Chemical class C1CCC1.C1=CN=CN=C1 UPUOLJWYFICKJI-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229960003085 meticillin Drugs 0.000 description 2
- 238000001690 micro-dialysis Methods 0.000 description 2
- 238000010172 mouse model Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 201000004939 Fanconi anemia Diseases 0.000 description 1
- 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
- 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
- 206010024774 Localised infection Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000005025 clonogenic survival Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 238000012829 orthopaedic surgery Methods 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000009340 pathogen transmission Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- DKGDFQNNQSTBHA-UHFFFAOYSA-N pyrimidine;1h-pyrimidin-2-one Chemical compound C1=CN=CN=C1.O=C1N=CC=CN1 DKGDFQNNQSTBHA-UHFFFAOYSA-N 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 1
- 238000013334 tissue model Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0047—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
- A61L9/18—Radiation
- A61L9/20—Ultraviolet radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B2018/1807—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using light other than laser radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0654—Lamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0655—Tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
- A61N2005/0667—Filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
Definitions
- Exemplary embodiments of the present disclosure relate to selectively affecting and/or killing bacteria, and more specifically to exemplary apparatus, methods and systems which can use an ultraviolet radiation to selectively affecting and/or killing bacteria while not harming human cells.
- SSI surgical site infections
- UV radiation can be a hazard both to the patient and to the operating team, and the use of additional clothing, hoods, and eye shields for protection can be both cumbersome and costly, preventing widespread use of the technique.
- UV radiation can be a very efficient bactericidal agent, and the mechanisms by which it mutates and kills bacteria, as well as human cells, are well established (see, e.g., Mitchell D L, Nairn R S. The biology of the (6-4) photoproduct. Photochem Photobiol 1989; 49(6):805-19; Witkin E M. Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol Rev 1976; 40(4):869-907; Koch-Pain C A, Amundson S A, Bittner M L, Meltzer P S, Fornace A J, Jr. Functional genomics of UV radiation responses in human cells. Mutat. Res. 2004; 549(1-2):65-78; and Harm W.
- UVGI Ultraviolet germicidal irradiation
- UVGI typically uses a short wavelength of UV, typically in the UVB or UVC range, to destroy nucleic acids in small organisms, removing their reproductive capabilities.
- UV irradiation is typically produced with low-pressure mercury lamps, which can produce a range of UV wavelengths, ranging from UVA (wavelengths 400 to 320 nm) to UVB (wavelengths 320 to 290 nm) to UVC (wavelengths 290 to 100 nm).
- UVGI is typically produced by mercury-vapor lamps that emit at around 254 nm.
- UVGI lamps may be harmful to humans and other life forms, and are typically shielded or in environments where exposure is limited.
- UV lamps can also facilitate a UV emission from an excited molecule complex (e.g., an exciplex, such as either krypton-bromine or krypton-chlorine), using arrangements called excilamps.
- an excited molecule complex e.g., an exciplex, such as either krypton-bromine or krypton-chlorine
- excilamps The basic theory behind exciplex UV emission was developed in the 1970s (see, e.g., Lorents D C. A model of rare - gas excimer formation and decay and its application to vuv lasers. Radiat. Res. 1974; 59(2):438-40; and Measures R M Prospects for developing a laser based on electrochemiluminescence. Appl Opt 1974; 13(5):1121-33).
- the first excimer lasers were made in the 1980s and they are now in common use, for example, e.g., in LASIK opthalmic surgery (see, e.g., Pallikaris I G, Papatzanaki M E, Stathi E Z, Frenschock O, Georgiadis A. Laser in situ keratomileusis. Lasers Surg Med 1990; 10(5):463-8).
- Current excimer lasers are typically not feasible for wound sterilization both in terms of beam size (e.g., excimer laser beams are very narrow) and their high cost.
- an excimer lamp (excilamp) has been developed in Russia (see, e.g., Sosnin E A, Oppenlander T, Tarasenko V F. Applications of capacitive and barrier discharge excilamps in photoscience. J. Photochem. Photobiol C: Photochem. Rev. 2006; 7:145-63), which can produce a wide high-intensity beam of single-wavelength UV radiation.
- These lamps can be small, inexpensive (e.g., ⁇ $1,000), high powered (e.g., wound irradiation time can be a few seconds), and long-lived (e.g., 1,000 to 10,000 hours).
- exemplary embodiments of the apparatus, methods and systems can be provided that can address at least some of such deficiencies.
- the exemplary embodiments of the apparatus, methods and systems can use an ultraviolet radiation to selectively affecting and/or killing bacteria while not harming human cells.
- a UV irradiator e.g., the excilamp
- the exemplary system, method and apparatus takes into consideration that bacteria are typically physically much smaller than human cells, and thus, an appropriately chosen UV wavelength (e.g., around 207 nm to 220 nm) preferably penetrates and kills bacteria, but preferably would not be able to penetrate into the biologically sensitive nucleus of human cells.
- Irradiating a wound with this exemplary tailored UV radiation can therefore provide the advantages of UV bacteriological sterilization, while being safe for patient and staff, and preferably not requiring protective clothing/hoods/eye shields, or the like.
- the room air (as opposed to the wound), or surfaces e.g., walls, floors, ceiling, countertops, furniture, fixtures, etc.
- surfaces e.g., walls, floors, ceiling, countertops, furniture, fixtures, etc.
- exemplary UV lamps that can emit at a single wavelength, in contrast to standard mercury UV lamps which typically emit over a wide range of wavelengths.
- the exemplary lamps can include UV emitted from an excited molecule complex (e.g., an exciplex, such as either krypton-bromine or krypton-chlorine), called excilamps, and can be modified in accordance with certain exemplary embodiments of the present disclosure to produce UV having a single wavelength, thus, facilitating modifying the UV irradiation to have enough energy to penetrate and kill bacteria, but not enough range to penetrate to the nucleus of human cells.
- This can be performed based on certain exemplary embodiments, e.g., using one or more modulators, wavelength-effecting masks, etc.
- Certain exemplary embodiments of the present disclosure can be tested, for example, in an in-vitro (laboratory) human skin system (see, e.g., Belyakov O V, Mitchell S A, Parikh D, Randers-Pehrson G, Marino S, Amundson S A, et al. Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc. Natl. Acad. Sci. U.S.A. 2005; 102:14203-08; and Su Y, Meador J A, Geard C R, Balajee A S. Analysis of ionizing radiation - induced DNA damage and repair in threedimensional human skin model system.
- CD 4 + T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections.
- Proc. Natl. Acad. Sci. U.S.A. 2006; 103(27):10408-13) in a nude mouse model for in-vivo safety standards, in large animal studies, or in studies in the clinic.
- the exemplary excilamp wound irradiation can facilitate a practical and inexpensive approach to significantly reducing surgical site infections.
- a UV radiation at approximately 207 nm to 220 nm can be provided, for example, that can differentially damage and/or kill methicillin-resistant Staphylococcus aureus (MRSA), relative to human cells.
- MRSA methicillin-resistant Staphylococcus aureus
- a conventional germicidal UV lamp can be approximately equally efficient at killing MRSA and human cells
- the exemplary 207 to 220 nm wavelength UV from excilamps can be approximately 5,000 times more efficient at killing MRSA relative to human cells.
- apparatus and method for generating at least one radiation can be provided.
- the exemplary apparatus and/or method can selectively kill and/or affect at least one bacteria.
- a radiation source first arrangement configured to generate at least one radiation having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement configured to substantially prevent the at least one radiation from having any wavelength that is outside of the range can be provided.
- the radiation can be configured to selectively affect or destroy at least one bacteria on or within a body, while substantially avoiding harm to cells of the body.
- the radiation source can include a krypton-bromine lamp or a krypton-chlorine lamp excilamp. Additionally, the radiation source first arrangement can be further configured to generate the at least one radiation having a single wavelength provided in the range, and the at least one second arrangement can be further configured to prevent the radiation from having any wavelength other than the single wavelength.
- the single wavelength can be about 207 nm, and/or about 222 nm. Further, the second arrangement can include at least one of a chemical filter or a dielectric.
- systems and methods can be provided for generating at least one radiation. For example, e.g., using a radiation source first arrangement or another arrangement, it is possible to generate the radiation(s) having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm. Further, it is possible to, using at least one second arrangement and/or the same arrangement, to substantially prevent the radiation(s) from having any wavelength that is outside of the range.
- the radiation(s) can be configured to selectively affect or destroy at least one bacteria on or within a body, while substantially avoiding harming to any of cells of the body.
- the radiation source can include an excilamp, a krypton-bromine lamp and/or a krypton-chlorine lamp.
- the radiation source first arrangement can be further configured to generate the radiation(s) having a single wavelength provided in the range, and the second arrangement(s) can be further configured to prevent the radiation(s) from having any wavelength other than the single wavelength.
- the single wavelength can be about 206 nm, 207 nm, and/or 222 nm.
- the second arrangement can include a chemical filter and/or a dielectric.
- FIG. 1 is a graph of an exemplary spectrum of UV wavelengths generated by a typical mercury UV lamp
- FIG. 2 is an illustration of an exemplary penetration of low wavelength UV radiation with respect to human cells and bacteria in accordance with an exemplary embodiment of the present disclosure
- FIG. 3 is an illustration of an exemplary excilamp which can provide the UV radiation with at a single wavelength or in a particular range of wavelengths in accordance with an exemplary embodiment of the present disclosure
- FIG. 4 is a graph of the exemplary spectral distributions of the UV radiation generated by excilamps in accordance with certain exemplary embodiments of the present disclosure
- FIG. 5 is an exemplary block diagram of an apparatus according to particular exemplary embodiments of the present disclosure.
- FIGS. 6( a ) and 6 ( b ) are spectral graphs of exemplary excilamps according to certain exemplary embodiments of the present disclosure
- FIG. 7 is a graph of human cell survival with respect to ultra violet fluence, according to certain exemplary embodiments of the present disclosure.
- FIG. 8 is a graph of MRSA survival with respect town excilamp fluence according to certain exemplary embodiments of the present disclosure.
- FIG. 9( a ) is a graph of exemplary yields for pre-mutagenic DNS lesions for cyclobutane pyrimidine dimers.
- FIG. 9( b ) is a graph of exemplary yields for pre-mutagenic DNS lesions for pyrimidine-pyrimidone 6-4 photoproducts (6-4PP).
- UV radiations of different wavelengths can have different abilities to penetrate into cells. Typically, the higher the wavelength, the more penetrating the radiation, and the lower the wavelength, the less penetrating the radiation.
- UV radiation with a low wavelength of about 200 nm, for example, while able to pass through water quite efficiently, can be heavily absorbed in the outer part of a human cell (the cytoplasm, see, for example, FIG. 2 ), and may not have enough energy to reach the biologically sensitive cell nucleus.
- the limited penetrating ability of ⁇ 200 nm UV radiation can be used, as shown in FIG. 2 , because bacteria are typically physically far smaller than human cells. Specifically, a typical bacterial cell is less than about 1 ⁇ m (micrometer) in diameter, whereas human cells are typically about 10 to 30 ⁇ m across, depending on their type and location.
- FIG. 2 shows a typical human cell nucleus having a spherical geometry 202 or a flattened geometry 204 , illustrating the penetration into a human cell of UV radiation with wavelength of around 200 nm.
- essentially no UV of this wavelength preferably reaches the cell nucleus 202 , 204 , which contains the radiation-sensitive DNA.
- UV radiation of this wavelength would typically not be harmful to human cells or thus to humans.
- there can be a biological reason why UV with a wavelength around 200 nm UV will typically not be harmful to humans.
- UV can be very efficiently absorbed by oxygen, producing ozone and oxidative damage.
- UV can be very efficient at producing oxidative DNA base damage (see, e.g., Kvam E, Tyrrell R M. Induction of oxidative DNA base damage in human skin cells by UV and near visible radiation. Carcinogenesis 1997; 18(12):2379-84; and Pattison D I, Davies M J, Actions of ultraviolet light on cellular structures. EXS 2006(96):131-57).
- 200 nm wavelength UV can be in a narrow UV “safety window”.
- bacteria are typically physically much smaller in size than human cells, UV radiation with wavelength around 200 nm can penetrate through, and therefore kill, bacteria.
- UV excilamps which, in contrast to standard UV lamps, can produce UV radiation at a specific wavelength—e.g., around 200 nm.
- UV radiation around such exemplary wavelength e.g., a single wavelength or in a range of certain wavelengths as described herein
- the exemplary excilamp technology can utilize certain exemplary concepts which were developed at the Institute of High Current Electronics (IHCE) in Tomsk, Siberia (see, e.g., Sosnin E A, Oppenlander T, Tarasenko V F. Applications of capacitive and barrier discharge excilamps in photoscience. J. Photochem. Photobiol C: Photochem. Rev. 2006; 7:145-63.). Additional exemplary excilamps that can be utilized with the exemplary embodiments of the present disclosure may be available from Heraeus Noblelight in Germany.
- the IHCE lamps, an exemplary embodiment of such lamp 302 is shown in FIG. 3 , can be small, rugged, cost ⁇ $1,000, and can be made to produce a variety of single wavelength UV radiations.
- exemplary embodiments of the present disclosure can use, for example, a krypton-bromine lamp excilamp, which can produce UV at about 207 nm, or a krypton-chlorine lamp ( FIG. 3 ), which can produce UV at about 222 nm.
- a krypton-chlorine lamp FIG. 3
- Another exemplary excilamp can produce UV at about 206 nm.
- the exemplary spectrum of these lamps are shown in the graph of FIG. 4 .
- a spectral distribution 402 can be produced by a krypton-bromine lamp
- spectral distribution 404 was produced by a krypton-chlorine lamp.
- certain exemplary features can be included (e.g., spectrum filtering elements such as multilayer dielectric filters or chemical filters) to remove unwanted wavelengths, or those wavelengths that are outside of the preferable range of wavelengths.
- spectrum filtering elements such as multilayer dielectric filters or chemical filters
- absorption and/or reflective elements can be provided between the lamp and the irradiated surface to filter unwanted wavelengths, such as, e.g., a band-pass filter, a long-wavelength blocking filter.
- the absorptive material can be fluorescent, such that it emits visible light when it absorbs UV radiation to provide an indication that the lamp is operating.
- other gases can be added to the lamp to suppress unwanted wavelengths. For example, adding argon to the krypton-chlorine lamp can suppress generation of the 228 nm UV.
- the typical power output of the air-cooled exc lamps can be about 7.5 to 20 mW/cm 2 , although higher power can be obtained in a water-cooled system. At about 20 mW/cm 2 , only a few seconds of exposure can deliver about 20 mJ/cm 2 , which can be a typical bactericidal dose.
- Exemplary embodiments of the present disclosure can provide an excilamp, emitting about a 207 nm or about a 222 nm single wavelength UV radiation, to differentially kill bacteria while sparing adjacent human cells. Further, the wavelength(s) of the UV radiation according to further exemplary embodiments of the present disclosure can be in the range of about 190 nanometers (nm) to about 230 nm. Exemplary experiments implementing embodiments of the present disclosure can include: an in-vitro (laboratory) 3-D human skin system (see, e.g, Belyakov O V, Mitchell S A, Parikh D, Randers-Pehrson G, Marino S, Amundson S A, et al.
- excilamp irradiation can be provided for a wound, a room air and/or surfaces (e.g., walls, floors, ceiling, countertops, furniture, fixtures, etc.), which can facilitate a practical and inexpensive approach to significantly reducing surgical wound infection.
- surfaces e.g., walls, floors, ceiling, countertops, furniture, fixtures, etc.
- an exemplary test bench was developed for gathering, e.g., exemplary preliminary sterilization results from exemplary UV light sources.
- the exemplary test bench can include: a) a light-tight box; b) a shutter control; c) a filter holder; and d) adjustable exposure parameters for time, distance, and wavelength (e.g., 207 nm KrBr excilamp, 222 nm, KrCl excilamp, and 254 nm standard germicidal lamp).
- exemplary custom filters can be designed to eliminate higher-wavelength components in the excilamp emission spectra to provide optimal single-wavelength exposure.
- a UV spectrometer and deuterium lamp can be used to validate the filter effectiveness, as shown, for example, in FIGS. 6( a ) and 6 ( b ), which illustrate the normalized spectra comparing excilamp emission (red— 602 a and 602 b ) with filtered excilamp emission (blue— 604 a and 604 b ) for both KrBr and KrCl excilamps.
- This exemplary test bench facilitated, for example, a generation of biological findings of filtered excilamp exposure to both bacteria and healthy human cells, which are described below.
- the exemplary biological testing experience has provided details regarding exemplary parameters for developing filtered KrBr and KrCl excilamps into optimal devices for clinical applications.
- the exemplary experiments investigated, for example, whether UV from exemplary filtered excilamps can be effective at killing bacteria while sparing normal human cells.
- human fibroblasts were, for example, exposed to about 3 mJ/cm 2 from a standard germicidal UV lamp (e.g., 254 nm), and their survival was less than about 10 ⁇ 4 .
- a standard germicidal UV lamp e.g. 254 nm
- their survival was in the range from about 1 to about 10 ⁇ 1 (see FIG. 7 ).
- FIG. 7 shows an exemplary graph indicating a clonogenic survival of normal human skin fibroblasts (AG1522) exposed to UV from exemplary filtered KrBr (207 nm) or KrCl (222 nm) excilamps or from a conventional germicidal lamp (254 nm).
- MRSA methicillin resistant Staphylococcus aureus
- MRSA can be the cause of about 25% of surgical site infection and can be associated with approximately 20,000 deaths per year in the United States, mostly healthcare related.
- MRSA and antibiotic-susceptible S. aureus are typically equally susceptible to UV from conventional germicidal lamps.
- Conner-Kerr T A Sullivan P K, Gaillard J, Franklin M E, Jones R M. The effects of ultraviolet radiation on antibiotic - resistant bacteria in vitro. Ostomy Wound Manage. 1998; 44(10):50-6).
- the exemplary results are shown, for example, in FIG.
- FIG. 8 shows an exemplary graph of MRSA (strain US300) inactivation after exposure to UV from the exemplary filtered KrBr or KrCl excilamps (207 nm and 222 nm, respectively).
- the exemplary filtered excilamp UV radiation at 207 nm and at 222 nm can differentially effect and/or kill MRSA relative to the human cells.
- the survival level of human cells is, for example, in the range of about 0.1 to 1, while the survival level of MRSA is in the range of about 10 ⁇ 4 .
- Such exemplary finding are in considerable contrast to the situation for convention germicidal UV lamps (GUVL), which is roughly equally efficient at killing bacteria and human cells.
- GUIL convention germicidal UV lamps
- the human cell survival from the GUVL is about 0.3 ⁇ 10 ⁇ 4 , a human cell survival advantage of 0.3.
- the human cell survival by the exemplary filtered exilamps is in the range of about 0.1 to 1, a human cell survival advantage in the range of 5,000.
- FIGS. 9( a ) and 9 ( b ) illustrate the exemplary measured induced yields of cyclobutane pyrimidine dimers (CPD) lesions ( FIGS. 9( a )) and 6-4 photoproducts (6-4PP, FIG. 9( b )) after exposure of the exemplary 3-D skin tissue model to the broad UV spectrum from a conventional germicidal UV lamp (e.g., peak 254 nm) or to an exemplary 207-nm light 905 from the Kr—Br excimer lamp.
- the exemplary germicidal lamp produced high yields of both pre-mutagenic skin DNA lesions. However after 207-nm exposure, neither lesion showed an induced yield which was significantly elevated above zero, at any of the studied fluences.
- the exemplary 207-nm light can kill MRSA much more efficiently than it can kill human cells. For example at a fluence of approximately 207-nm, the light can produce four logs of MRSA cell kill, and there is much less than one decade of cell kill in human cells. In contrast with the results for 207-nm light, while conventional germicidal lamps 910 can efficiently kill MRSA, conventional germicidal lamps are also almost as efficient at killing human cells. Quantitatively, for a four-log level of MRSA killing, 207-nm UV light can produce about 1,000-fold less human cell killing than a conventional germicidal UVC lamp.
- UV wavelengths have been suggested as potentially being safe for human exposure, in particular 405 nm (see, e.g., McDonald R S, Gupta S, Maclean M, Ramakrishnan P, Anderson J G, et al. (2013) 405 nm Light exposure of osteoblasts and inactivation of bacterial isolates from arthroplasty patients: potential for new disinfection applications? Eur Cell Mater 25: 204-214)and 254 nm (see, e.g., Dai T, Vrahas M S, Murray C K, Hamblin M R (2012) Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections?
- the exemplary 207-nm light from a Kr—Br excimer lamp can have considerable potential for safely reducing SSI rates.
- Such lamps can be used in an operating room environment without the need for protective clothing for the staff or the patient.
- 207-nm light can be used for continuous low-fluence-rate exposure during a surgical procedure, because current evidence suggests that the majority of SSI can result from bacteria alighting directly onto the surgical wound from the air.
- Evidence for the dominance of an airborne route can come from correlations between the density of airborne bacteria and postoperative sepsis rates. (See, e.g., Lidwell O M, Lowbury E J, Whyte W Blowers R, Stanley S J, et al.
- a continuous low-fluence-rate exposure of 207-nm UV light onto the surgical wound area during the complete surgical procedure can kill bacteria as they alight onto the wound area.
- Such exemplary continuous exposure can be designed to inactivate bacteria before the bacteria can penetrate into the interior of the wound.
- a second advantage associated with targeting bacteria as the bacteria alight onto the wound area is in relation to biofilms. (See, e.g., Frei E, Hodgkiss-Harlow K, Rossi P J, Edmiston C E, Jr., Bandyk D F (2011) Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovascular Surg 45: 688-696).
- bacteria can typically be in individual planktonic form, and thus, can be amenable to killing by 207-nm light. This can prevent the subsequent formation of bacterial clusters (e.g., biofilms), which can be refractory to 207-nm light as they are to most other therapies.
- bacterial clusters e.g., biofilms
- exemplary 207-nm lamp in a surgical setting can be possible. It is important that surgical staff do not inadvertently block the UV light, so one exemplary arrangement can be for the excimer lamp to be incorporated into a standard overhead surgical illumination system.
- a possible second exemplary UV light source, to ensure a level of redundancy from inadvertent shielding, can be incorporation into a surgeon's headlight illumination system, with the UV light transmitted to the headlight via fiber optics.
- Rotterdam KPN Telecom tower See, e.g., Tscherteu G, Lervig M C, Brynskov M. KPN Tower, Rotterdam, 2000; 2012; Aarhus, Denmark. Media Architecture Institute Vienna/Sydney and Aarhus University).
- the exemplary 207-nm UV light can be used to treat, on a continuous basis, any airborne environment where there is a high likelihood of airborne-based pathogen transmission (e.g., Tuberculosis or the pandemic influenza).
- airborne-based pathogen transmission e.g., Tuberculosis or the pandemic influenza.
- upper-room UV irradiation systems have long been considered, based on conventional broad-spectrum UV lamps (see, e.g., Reed N G (2010) The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep 125: 15-27), and have shown some promise(see, e.g., Nardell E A, Bucher S J, Brickner P W, Wang C, Vincent R L, et al.
- FIG. 5 shows an exemplary block diagram of an exemplary embodiment of a system according to the present disclosure.
- exemplary procedures in accordance with the present disclosure described herein can be performed by or controlled using a UV generation source 580 and/or hardware processing arrangement and/or a computing arrangement 510 , separately and in conjunction with one another.
- Such exemplary processing/computing arrangement 510 can be, e.g., entirely or a part of, or include, but not limited to, a computer/processor 520 that can include, e.g., one or more microprocessors, and use instructions stored on a computer-accessible medium (e.g., RAM, ROM, hard drive, or other storage device).
- a computer-accessible medium e.g., RAM, ROM, hard drive, or other storage device.
- a computer-accessible medium 530 e.g., as described herein above, a storage device such as a hard disk, floppy disk, memory stick, CD-ROM, RAM, ROM, etc., or a collection thereof
- the computer-accessible medium 530 can contain executable instructions 540 thereon.
- a storage arrangement 550 can be provided separately from the computer-accessible medium 530 , which can provide the instructions to the processing arrangement 510 so as to configure the processing arrangement to execute certain exemplary procedures, processes and methods, as described herein above, for example.
- the exemplary processing arrangement 510 can be provided with or include an input/output arrangement 570 , which can include, e.g., a wired network, a wireless network, the internet, an intranet, a data collection probe, a sensor, etc.
- the exemplary processing arrangement 510 can be in communication with an exemplary display arrangement 560 , which, according to certain exemplary embodiments of the present disclosure, can be a touch-screen configured for inputting information to the processing arrangement in addition to outputting information from the processing arrangement, for example.
- the exemplary display 560 and/or a storage arrangement 550 can be used to display and/or store data in a user-accessible format and/or user-readable format.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Electromagnetism (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Radiation-Therapy Devices (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
- This application claims priority to U.S. Provisional Application Ser. No. 61/450,038, filed on Mar. 7, 2011, and International Application No. PCT/US2012/027963, filed on Mar. 7, 2012, the disclosures of which are incorporated by reference herein in their entirety.
- Exemplary embodiments of the present disclosure relate to selectively affecting and/or killing bacteria, and more specifically to exemplary apparatus, methods and systems which can use an ultraviolet radiation to selectively affecting and/or killing bacteria while not harming human cells.
- It has been estimated that between 2% and 5% of clean surgeries result in surgical site infections (SSI). Patients who develop SSI can be 60% more likely to spend time in an ICU, can be 5 times as likely to be readmitted, can have a mortality rate twice that of noninfected patients, can have an average of 7 days additional length of hospital stay, and can have an average of about $3,000 additional costs. It has been estimated that about 40-60% of SSIs can be preventable (see, e.g., Barie P S, Eachempati S R. Surgical site infections. Surg Clin North Am 2005; 85(6):1115-35, viii-ix).
- It has been approximately 50 years since Deryl Hart and colleagues at Duke University showed that ultraviolet (UV) irradiation of surgical wounds can be a highly effective methodology for reducing surgical wound infection rates (see, e.g., Hart D. Bactericidal ultraviolet radiation in the operating room. Twenty-nine-year study for control of infections. J Am Med Assoc 1960; 172:1019-28). However, UV radiation can be a hazard both to the patient and to the operating team, and the use of additional clothing, hoods, and eye shields for protection can be both cumbersome and costly, preventing widespread use of the technique.
- UV radiation can be a very efficient bactericidal agent, and the mechanisms by which it mutates and kills bacteria, as well as human cells, are well established (see, e.g., Mitchell D L, Nairn R S. The biology of the (6-4) photoproduct. Photochem Photobiol 1989; 49(6):805-19; Witkin E M. Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli. Bacteriol Rev 1976; 40(4):869-907; Koch-Pain C A, Amundson S A, Bittner M L, Meltzer P S, Fornace A J, Jr. Functional genomics of UV radiation responses in human cells. Mutat. Res. 2004; 549(1-2):65-78; and Harm W. Biological effects of ultraviolet radiation. Cambridge, UK: Cambridge University Press, 1980). Ultraviolet germicidal irradiation (UVGI) has been used to break down microorganisms in food, air, and water purification, UVGI typically uses a short wavelength of UV, typically in the UVB or UVC range, to destroy nucleic acids in small organisms, removing their reproductive capabilities. UV irradiation (including UVGI) is typically produced with low-pressure mercury lamps, which can produce a range of UV wavelengths, ranging from UVA (wavelengths 400 to 320 nm) to UVB (
wavelengths 320 to 290 nm) to UVC (wavelengths 290 to 100 nm).FIG. 1 shows the spectrum of UV wavelengths emitted from a typical mercury UV lamp. UVGI is typically produced by mercury-vapor lamps that emit at around 254 nm. However, UVGI lamps may be harmful to humans and other life forms, and are typically shielded or in environments where exposure is limited. - UV lamps can also facilitate a UV emission from an excited molecule complex (e.g., an exciplex, such as either krypton-bromine or krypton-chlorine), using arrangements called excilamps. The basic theory behind exciplex UV emission was developed in the 1970s (see, e.g., Lorents D C. A model of rare-gas excimer formation and decay and its application to vuv lasers. Radiat. Res. 1974; 59(2):438-40; and Measures R M Prospects for developing a laser based on electrochemiluminescence. Appl Opt 1974; 13(5):1121-33). The first excimer lasers were made in the 1980s and they are now in common use, for example, e.g., in LASIK opthalmic surgery (see, e.g., Pallikaris I G, Papatzanaki M E, Stathi E Z, Frenschock O, Georgiadis A. Laser in situ keratomileusis. Lasers Surg Med 1990; 10(5):463-8). Current excimer lasers, however, are typically not feasible for wound sterilization both in terms of beam size (e.g., excimer laser beams are very narrow) and their high cost. In the past, an excimer lamp (excilamp) has been developed in Russia (see, e.g., Sosnin E A, Oppenlander T, Tarasenko V F. Applications of capacitive and barrier discharge excilamps in photoscience. J. Photochem. Photobiol C: Photochem. Rev. 2006; 7:145-63), which can produce a wide high-intensity beam of single-wavelength UV radiation. These lamps can be small, inexpensive (e.g., ˜$1,000), high powered (e.g., wound irradiation time can be a few seconds), and long-lived (e.g., 1,000 to 10,000 hours). Certain papers (see, e.g., Sosnin E A, Avdeev S M, Kuznetzova E A, Lavrent'eva L V. A bacterial barrier-discharge KrBr Excilamp. Instr. Experiment. Tech. 2005; 48:663-66; Matafonova G G, Batoev V B, Astakhova S A, Gomez M, Christofi N. Efficiency of KrCl excilamp (222 nm) for inactivation of bacteria in suspension. Lett Appl Microbiol 2008; 47(6):508-13; and Wang D, Oppenlander T, El-Din M G, Bolton J R. Comparison of the disinfection effects of vacuum-UV (VUV) and UV light on Bacillus subtilis spores in aqueous suspensions at 172, 222 and 254 nm. Photochem Photobiol 2010; 86(1):176-81) have been published on their bactericidal properties (as expected they are highly efficient), but the concept that these lamps will kill bacteria but not human cells is not described.
- Thus, there may be a need to address at least some of the deficiencies and/or issues that to date remained with respect to the above-described conventional systems and methods.
- Accordingly, exemplary embodiments of the apparatus, methods and systems can be provided that can address at least some of such deficiencies. For example, the exemplary embodiments of the apparatus, methods and systems can use an ultraviolet radiation to selectively affecting and/or killing bacteria while not harming human cells.
- In particular, in certain exemplary embodiments of the present disclosure, a UV irradiator, e.g., the excilamp, can be provided which can effect and/or kill bacteria, without being harmful to human cells. The exemplary system, method and apparatus takes into consideration that bacteria are typically physically much smaller than human cells, and thus, an appropriately chosen UV wavelength (e.g., around 207 nm to 220 nm) preferably penetrates and kills bacteria, but preferably would not be able to penetrate into the biologically sensitive nucleus of human cells. Irradiating a wound with this exemplary tailored UV radiation, for example, can therefore provide the advantages of UV bacteriological sterilization, while being safe for patient and staff, and preferably not requiring protective clothing/hoods/eye shields, or the like. According to another exemplary embodiment of the present disclosure, the room air (as opposed to the wound), or surfaces (e.g., walls, floors, ceiling, countertops, furniture, fixtures, etc.) can be exposed to this exemplary UV lamp in hospital environments.
- According to further exemplary embodiments of the present disclosure, it is possible to provide exemplary UV lamps that can emit at a single wavelength, in contrast to standard mercury UV lamps which typically emit over a wide range of wavelengths. The exemplary lamps can include UV emitted from an excited molecule complex (e.g., an exciplex, such as either krypton-bromine or krypton-chlorine), called excilamps, and can be modified in accordance with certain exemplary embodiments of the present disclosure to produce UV having a single wavelength, thus, facilitating modifying the UV irradiation to have enough energy to penetrate and kill bacteria, but not enough range to penetrate to the nucleus of human cells. This can be performed based on certain exemplary embodiments, e.g., using one or more modulators, wavelength-effecting masks, etc.
- Certain exemplary embodiments of the present disclosure can be tested, for example, in an in-vitro (laboratory) human skin system (see, e.g., Belyakov O V, Mitchell S A, Parikh D, Randers-Pehrson G, Marino S, Amundson S A, et al. Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc. Natl. Acad. Sci. U.S.A. 2005; 102:14203-08; and Su Y, Meador J A, Geard C R, Balajee A S. Analysis of ionizing radiation-induced DNA damage and repair in threedimensional human skin model system. Exp Dermatol 2010; 19(8):e16-22), in an in-vitro wound infection model (see, e.g., Giannini G T, Boothby J T, Sabelman E E. Infected wound model development of an in vitro biomaterial-protected wound infection model to study microbial activity and antimicrobial treatment through microdialysis. Adv Skin Wound Care 2010; 23(8):358-64), in a clinically relevant mouse model of surgical wound infection (see, e.g., McLoughlin R M, Solinga R M, Rich J, Zaleski K J, Cocchiaro J L, Risley A, et al. CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc. Natl. Acad. Sci. U.S.A. 2006; 103(27):10408-13), in a nude mouse model for in-vivo safety standards, in large animal studies, or in studies in the clinic. The exemplary excilamp wound irradiation can facilitate a practical and inexpensive approach to significantly reducing surgical site infections.
- According to certain exemplary embodiments of the present disclosure, a UV radiation at approximately 207 nm to 220 nm can be provided, for example, that can differentially damage and/or kill methicillin-resistant Staphylococcus aureus (MRSA), relative to human cells. Although a conventional germicidal UV lamp can be approximately equally efficient at killing MRSA and human cells, by contrast, the exemplary 207 to 220 nm wavelength UV from excilamps can be approximately 5,000 times more efficient at killing MRSA relative to human cells.
- According to certain exemplary embodiments of the present disclosure, apparatus and method for generating at least one radiation can be provided. According to certain exemplary embodiments, the exemplary apparatus and/or method can selectively kill and/or affect at least one bacteria. For example, a radiation source first arrangement configured to generate at least one radiation having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement configured to substantially prevent the at least one radiation from having any wavelength that is outside of the range can be provided. The radiation can be configured to selectively affect or destroy at least one bacteria on or within a body, while substantially avoiding harm to cells of the body. The radiation source can include a krypton-bromine lamp or a krypton-chlorine lamp excilamp. Additionally, the radiation source first arrangement can be further configured to generate the at least one radiation having a single wavelength provided in the range, and the at least one second arrangement can be further configured to prevent the radiation from having any wavelength other than the single wavelength. The single wavelength can be about 207 nm, and/or about 222 nm. Further, the second arrangement can include at least one of a chemical filter or a dielectric.
- According to yet another exemplary embodiment, systems and methods can be provided for generating at least one radiation. For example, e.g., using a radiation source first arrangement or another arrangement, it is possible to generate the radiation(s) having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm. Further, it is possible to, using at least one second arrangement and/or the same arrangement, to substantially prevent the radiation(s) from having any wavelength that is outside of the range.
- The radiation(s) can be configured to selectively affect or destroy at least one bacteria on or within a body, while substantially avoiding harming to any of cells of the body. The radiation source can include an excilamp, a krypton-bromine lamp and/or a krypton-chlorine lamp. The radiation source first arrangement can be further configured to generate the radiation(s) having a single wavelength provided in the range, and the second arrangement(s) can be further configured to prevent the radiation(s) from having any wavelength other than the single wavelength. The single wavelength can be about 206 nm, 207 nm, and/or 222 nm. The second arrangement can include a chemical filter and/or a dielectric.
- These and other objects, features and advantages of the present disclosure will become apparent upon reading the following detailed description of embodiments of the present disclosure in conjunction with the appended claims.
- Further objects, features and advantages of the present disclosure will become apparent from the following detailed description taken in conjunction with the accompanying Figures showing illustrative embodiments of the present disclosure, in which:
-
FIG. 1 is a graph of an exemplary spectrum of UV wavelengths generated by a typical mercury UV lamp; -
FIG. 2 is an illustration of an exemplary penetration of low wavelength UV radiation with respect to human cells and bacteria in accordance with an exemplary embodiment of the present disclosure; -
FIG. 3 is an illustration of an exemplary excilamp which can provide the UV radiation with at a single wavelength or in a particular range of wavelengths in accordance with an exemplary embodiment of the present disclosure; -
FIG. 4 is a graph of the exemplary spectral distributions of the UV radiation generated by excilamps in accordance with certain exemplary embodiments of the present disclosure; -
FIG. 5 is an exemplary block diagram of an apparatus according to particular exemplary embodiments of the present disclosure; -
FIGS. 6( a) and 6(b) are spectral graphs of exemplary excilamps according to certain exemplary embodiments of the present disclosure; -
FIG. 7 is a graph of human cell survival with respect to ultra violet fluence, according to certain exemplary embodiments of the present disclosure; -
FIG. 8 is a graph of MRSA survival with respect town excilamp fluence according to certain exemplary embodiments of the present disclosure; -
FIG. 9( a) is a graph of exemplary yields for pre-mutagenic DNS lesions for cyclobutane pyrimidine dimers; and -
FIG. 9( b) is a graph of exemplary yields for pre-mutagenic DNS lesions for pyrimidine-pyrimidone 6-4 photoproducts (6-4PP). - Throughout the drawings, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components, or portions of the illustrated embodiments. Moreover, while the present disclosure will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments and is not limited by the particular embodiments illustrated in the figures and the accompanying claims.
- UV radiations of different wavelengths can have different abilities to penetrate into cells. Typically, the higher the wavelength, the more penetrating the radiation, and the lower the wavelength, the less penetrating the radiation. For example, UV radiation with a low wavelength of about 200 nm, for example, while able to pass through water quite efficiently, can be heavily absorbed in the outer part of a human cell (the cytoplasm, see, for example,
FIG. 2 ), and may not have enough energy to reach the biologically sensitive cell nucleus. - The limited penetrating ability of ˜200 nm UV radiation can be used, as shown in
FIG. 2 , because bacteria are typically physically far smaller than human cells. Specifically, a typical bacterial cell is less than about 1 μm (micrometer) in diameter, whereas human cells are typically about 10 to 30 μm across, depending on their type and location. - In particular,
FIG. 2 shows a typical human cell nucleus having aspherical geometry 202 or a flattenedgeometry 204, illustrating the penetration into a human cell of UV radiation with wavelength of around 200 nm. As shown inFIG. 2 , essentially no UV of this wavelength preferably reaches thecell nucleus - According to exemplary embodiments of the present disclosure, it is possible to utilize one or more UV excilamps which, in contrast to standard UV lamps, can produce UV radiation at a specific wavelength—e.g., around 200 nm. UV radiation around such exemplary wavelength (e.g., a single wavelength or in a range of certain wavelengths as described herein) can penetrate and kill bacteria, but preferably would not penetrate into the nucleus of human cells, and thus, can be expected to be safe for both patient and staff.
- The exemplary excilamp technology can utilize certain exemplary concepts which were developed at the Institute of High Current Electronics (IHCE) in Tomsk, Siberia (see, e.g., Sosnin E A, Oppenlander T, Tarasenko V F. Applications of capacitive and barrier discharge excilamps in photoscience. J. Photochem. Photobiol C: Photochem. Rev. 2006; 7:145-63.). Additional exemplary excilamps that can be utilized with the exemplary embodiments of the present disclosure may be available from Heraeus Noblelight in Germany. The IHCE lamps, an exemplary embodiment of
such lamp 302 is shown inFIG. 3 , can be small, rugged, cost ˜$1,000, and can be made to produce a variety of single wavelength UV radiations. Based on the considerations above, exemplary embodiments of the present disclosure can use, for example, a krypton-bromine lamp excilamp, which can produce UV at about 207 nm, or a krypton-chlorine lamp (FIG. 3 ), which can produce UV at about 222 nm. Another exemplary excilamp can produce UV at about 206 nm. The exemplary spectrum of these lamps are shown in the graph ofFIG. 4 . As shown inFIG. 4 , aspectral distribution 402 can be produced by a krypton-bromine lamp, andspectral distribution 404 was produced by a krypton-chlorine lamp. Additionally, according to further exemplary embodiments of the present disclosure, certain exemplary features can be included (e.g., spectrum filtering elements such as multilayer dielectric filters or chemical filters) to remove unwanted wavelengths, or those wavelengths that are outside of the preferable range of wavelengths. For example, absorption and/or reflective elements can be provided between the lamp and the irradiated surface to filter unwanted wavelengths, such as, e.g., a band-pass filter, a long-wavelength blocking filter. In one exemplary embodiment, the absorptive material can be fluorescent, such that it emits visible light when it absorbs UV radiation to provide an indication that the lamp is operating. Alternatively or in addition, other gases can be added to the lamp to suppress unwanted wavelengths. For example, adding argon to the krypton-chlorine lamp can suppress generation of the 228 nm UV. - The typical power output of the air-cooled exc lamps can be about 7.5 to 20 mW/cm2, although higher power can be obtained in a water-cooled system. At about 20 mW/cm2, only a few seconds of exposure can deliver about 20 mJ/cm2, which can be a typical bactericidal dose.
- Exemplary embodiments of the present disclosure can provide an excilamp, emitting about a 207 nm or about a 222 nm single wavelength UV radiation, to differentially kill bacteria while sparing adjacent human cells. Further, the wavelength(s) of the UV radiation according to further exemplary embodiments of the present disclosure can be in the range of about 190 nanometers (nm) to about 230 nm. Exemplary experiments implementing embodiments of the present disclosure can include: an in-vitro (laboratory) 3-D human skin system (see, e.g, Belyakov O V, Mitchell S A, Parikh D, Randers-Pehrson G, Marino S, Amundson S A, et al. Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc. Natl. Acad. Sci. U.S.A. 2005; 102:14203-08; and Su Y, Meador J A, Geard C R, Balajee A S Analysis of ionizing radiation-induced DNA damage and repair in threedimensional human skin model system. Exp Dermatol 2010; 19(8);e16-22); a nude mouse model for in-vivo safety standards; an in-vitro wound infection model (see, e.g., Giannini G T, Boothby J T, Sabelman E E. Infected wound model development of an in vitro biomaterial-protected wound infection model to study microbial activity and antimicrobial treatment through microdialysis. Adv Skin Wound Care 2010; 23(8):358-64); a clinically relevant mouse model of surgical wound infection (see, e.g., McLoughlin R M Solinga R M Rich J, Zaleski K J, Cocchiaro J L, Risley A, et al. CD4+ T cells and CXC chemokines modulate the pathogenesis ofi Staphylococcus aureus wound infections. Proc. Natl. Acad. Sci. U.S.A. 2006; 103(27):10408-13); larger animal model studies; studies in a clinic. According to yet another exemplary embodiment of the present disclosure, excilamp irradiation can be provided for a wound, a room air and/or surfaces (e.g., walls, floors, ceiling, countertops, furniture, fixtures, etc.), which can facilitate a practical and inexpensive approach to significantly reducing surgical wound infection.
- In an exemplary experiment implementing certain exemplary embodiments of the present disclosure, an exemplary test bench was developed for gathering, e.g., exemplary preliminary sterilization results from exemplary UV light sources. For example, the exemplary test bench can include: a) a light-tight box; b) a shutter control; c) a filter holder; and d) adjustable exposure parameters for time, distance, and wavelength (e.g., 207 nm KrBr excilamp, 222 nm, KrCl excilamp, and 254 nm standard germicidal lamp). Additionally, exemplary custom filters can be designed to eliminate higher-wavelength components in the excilamp emission spectra to provide optimal single-wavelength exposure. A UV spectrometer and deuterium lamp (e.g., for equipment calibration) can be used to validate the filter effectiveness, as shown, for example, in
FIGS. 6( a) and 6(b), which illustrate the normalized spectra comparing excilamp emission (red—602 a and 602 b) with filtered excilamp emission (blue—604 a and 604 b) for both KrBr and KrCl excilamps. This exemplary test bench facilitated, for example, a generation of biological findings of filtered excilamp exposure to both bacteria and healthy human cells, which are described below. In turn, the exemplary biological testing experience has provided details regarding exemplary parameters for developing filtered KrBr and KrCl excilamps into optimal devices for clinical applications. - Described below are certain exemplary experiments implementing certain exemplary embodiments of the present disclosure. The exemplary experiments investigated, for example, whether UV from exemplary filtered excilamps can be effective at killing bacteria while sparing normal human cells.
- In the exemplary experiment, human fibroblasts were, for example, exposed to about 3 mJ/cm2 from a standard germicidal UV lamp (e.g., 254 nm), and their survival was less than about 10−4. By contrast, when they were exposed to fluences as high as 150 mJ/cm2 from the exemplary filtered KrBr or KrCl excilamp (e.g., 207 and 222 nm, respectively), their survival was in the range from about 1 to about 10−1 (see
FIG. 7 ). Indeed,FIG. 7 shows an exemplary graph indicating a clonogenic survival of normal human skin fibroblasts (AG1522) exposed to UV from exemplary filtered KrBr (207 nm) or KrCl (222 nm) excilamps or from a conventional germicidal lamp (254 nm). - In the exemplary experiment, bactericidal killing efficacy of the exemplary excilamps was tested, for example, on methicillin resistant Staphylococcus aureus (MRSA). MRSA can be the cause of about 25% of surgical site infection and can be associated with approximately 20,000 deaths per year in the United States, mostly healthcare related. MRSA and antibiotic-susceptible S. aureus are typically equally susceptible to UV from conventional germicidal lamps. (See, e.g., Conner-Kerr T A, Sullivan P K, Gaillard J, Franklin M E, Jones R M. The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro. Ostomy Wound Manage. 1998; 44(10):50-6). The exemplary results are shown, for example, in
FIG. 8 , indicating that at an excilamp fluence of about 100 mJ/cm2, an MRSA survival level of 10−4 can be achieved. For example,FIG. 8 shows an exemplary graph of MRSA (strain US300) inactivation after exposure to UV from the exemplary filtered KrBr or KrCl excilamps (207 nm and 222 nm, respectively). - Comparing the exemplary results in
FIGS. 7 and 8 , the exemplary filtered excilamp UV radiation at 207 nm and at 222 nm can differentially effect and/or kill MRSA relative to the human cells. For example, at exemplary filtered excilamp fluences of about 100 mJ/cm2, the survival level of human cells is, for example, in the range of about 0.1 to 1, while the survival level of MRSA is in the range of about 10−4. Such exemplary finding are in considerable contrast to the situation for convention germicidal UV lamps (GUVL), which is roughly equally efficient at killing bacteria and human cells. For example, for a conventional germicidal UV lamp, at a UV fluence for which a GUVL produces a bacterial survival of 10−4, the human cell survival from the GUVL is about 0.3×10−4, a human cell survival advantage of 0.3. With the exemplary excilamp at 207 or 222 nm, at a UV fluence for which the exemplary 207 or 222 nm filtered excilamp produces a bacterial survival of 10−4, the human cell survival by the exemplary filtered exilamps is in the range of about 0.1 to 1, a human cell survival advantage in the range of 5,000. -
FIGS. 9( a) and 9(b) illustrate the exemplary measured induced yields of cyclobutane pyrimidine dimers (CPD) lesions (FIGS. 9( a)) and 6-4 photoproducts (6-4PP,FIG. 9( b)) after exposure of the exemplary 3-D skin tissue model to the broad UV spectrum from a conventional germicidal UV lamp (e.g., peak 254 nm) or to an exemplary 207-nm light 905 from the Kr—Br excimer lamp. The exemplary germicidal lamp produced high yields of both pre-mutagenic skin DNA lesions. However after 207-nm exposure, neither lesion showed an induced yield which was significantly elevated above zero, at any of the studied fluences. - The exemplary 207-nm light can kill MRSA much more efficiently than it can kill human cells. For example at a fluence of approximately 207-nm, the light can produce four logs of MRSA cell kill, and there is much less than one decade of cell kill in human cells. In contrast with the results for 207-nm light, while conventional
germicidal lamps 910 can efficiently kill MRSA, conventional germicidal lamps are also almost as efficient at killing human cells. Quantitatively, for a four-log level of MRSA killing, 207-nm UV light can produce about 1,000-fold less human cell killing than a conventional germicidal UVC lamp. - In terms of the safety of 207-nm UV light, the lack of induction of typical UV-associated pre-mutagenic DNA lesions in the epidermis of a 3-D skin model is consistent with biophysical expectations based on the limited penetration of 207-nm UV light, and consistent with earlier studies using 193-nm laser light. (See, e.g., Green H, Boll J, Parrish J A, Kochevar I E, Oseroff A R (1987) Cytotoxicity and mutagenicity of low intensity, 248 and 193 nm excimer laser radiation in mammalian cells. Cancer Res 47: 410-413). While other UV wavelengths have been suggested as potentially being safe for human exposure, in particular 405 nm (see, e.g., McDonald R S, Gupta S, Maclean M, Ramakrishnan P, Anderson J G, et al. (2013) 405 nm Light exposure of osteoblasts and inactivation of bacterial isolates from arthroplasty patients: potential for new disinfection applications? Eur Cell Mater 25: 204-214)and 254 nm (see, e.g., Dai T, Vrahas M S, Murray C K, Hamblin M R (2012) Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther 10: 185-195), no mechanisms have been proposed for a differential toxic effect for bacteria vs. human cells at these wavelengths, and both 405-nm light (see, e.g., Papadopoulo D, Guillouf C, Mohrenweiser H, Moustacchi E (1990) Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc Natl Acad Sci USA 87: 8383-8387)and 254-nm light (see, e.g., Zolzer F Kiefer J (1984) Wavelength dependence of inactivation and mutation induction to 6-thioguanine-resistance in V79 Chinese hamster fibroblasts, Photochem Photobiol 40: 49-53)have been shown to be mutagenic to mammalian cells at relevant fluences.
- In contrast, the exemplary 207-nm light from a Kr—Br excimer lamp can have considerable potential for safely reducing SSI rates. Such lamps can be used in an operating room environment without the need for protective clothing for the staff or the patient. For example, 207-nm light can be used for continuous low-fluence-rate exposure during a surgical procedure, because current evidence suggests that the majority of SSI can result from bacteria alighting directly onto the surgical wound from the air. Evidence for the dominance of an airborne route can come from correlations between the density of airborne bacteria and postoperative sepsis rates. (See, e.g., Lidwell O M, Lowbury E J, Whyte W Blowers R, Stanley S J, et al. (1983) Airborne contamination of wounds in joint replacement operations: the relationship to sepsis rates. J Hosp Infect 4: 111-131; Gosden P E, MacGowan A P, Bannister G C (1998) Importance of air quality and related factors in the prevention of infection in orthopaedic implant surgery. J Hosp Infect 39: 173-180). Evidence for the significance of airborne bacteria alighting directly on the surgical wound can come from, for example, studies of conventional UV lamps specifically directed over the surgical site (see, e.g., Ritter M A, Olberding E M, Malinzak R A (2007) Ultraviolet lighting during orthopaedic surgery and the rate of infection. J Bone Joint Surg Am 89: 1935-1940), and also wound-directed filtered airflow studies. (See, e.g, Stocks G W, O'Connor D P, Self S D, Marcek G A, Thompson B L (2011) Directed airflow to reduce airborne particulate and bacterial contamination in the surgical field during total hip arthroplasty. J Arthroplasty 26: 771-776).
- Thus, a continuous low-fluence-rate exposure of 207-nm UV light onto the surgical wound area during the complete surgical procedure can kill bacteria as they alight onto the wound area. Such exemplary continuous exposure can be designed to inactivate bacteria before the bacteria can penetrate into the interior of the wound. A second advantage associated with targeting bacteria as the bacteria alight onto the wound area is in relation to biofilms. (See, e.g., Frei E, Hodgkiss-Harlow K, Rossi P J, Edmiston C E, Jr., Bandyk D F (2011) Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovascular Surg 45: 688-696). For example, as bacteria can alight onto the skin/wound, they can typically be in individual planktonic form, and thus, can be amenable to killing by 207-nm light. This can prevent the subsequent formation of bacterial clusters (e.g., biofilms), which can be refractory to 207-nm light as they are to most other therapies.
- Several configurations for the exemplary 207-nm lamp in a surgical setting can be possible. It is important that surgical staff do not inadvertently block the UV light, so one exemplary arrangement can be for the excimer lamp to be incorporated into a standard overhead surgical illumination system. A possible second exemplary UV light source, to ensure a level of redundancy from inadvertent shielding, can be incorporation into a surgeon's headlight illumination system, with the UV light transmitted to the headlight via fiber optics. (See, e.g., Miller J, Yu X-B, Yu P K, Cringle S J, Yu D-Y (2011) Development of a fiber-optic delivery system capable of delivering 213 and 266 nm pulsed Nd: YAG laser radiation for tissue ablation in a fluid environment. Appl Opt 50: 876-885).
- Commercial 207-nm excimer lamps can be inexpensive and long lived. In fact in a different wavelength range (e.g., 172 nm) xenon excimer lamps (see, e.g., Salvermoser M, Murnick D E (2003) High-efficiency, high-power, stable 172 nm xenon excimer light source. Appl Phys Lett 83: 1932-1934) with rated lifetimes of 50,000 to 100,000 hours, are already in commercial use (see, e,g,, Hitzschke L, Vollkommer F (2001) Product families based on dielectric barrier discharges. In: Bergman R S, editor. Proceedings of the Ninth International Symposium on the Science & Technology of Light Sources (LS:9). Ithaca, N.Y.: Cornell University Press. pp. 411-421), providing (e.g., using appropriate phosphors) both interior and exterior office lighting, for example on the Rotterdam KPN Telecom tower. (See, e.g., Tscherteu G, Lervig M C, Brynskov M. KPN Tower, Rotterdam, 2000; 2012; Aarhus, Denmark. Media Architecture Institute Vienna/Sydney and Aarhus University).
- In addition to direct bactericidal applications in surgical environments, the exemplary 207-nm UV light can be used to treat, on a continuous basis, any airborne environment where there is a high likelihood of airborne-based pathogen transmission (e.g., Tuberculosis or the pandemic influenza). While upper-room UV irradiation systems have long been considered, based on conventional broad-spectrum UV lamps (see, e.g., Reed N G (2010) The history of ultraviolet germicidal irradiation for air disinfection. Public Health Rep 125: 15-27), and have shown some promise(see, e.g., Nardell E A, Bucher S J, Brickner P W, Wang C, Vincent R L, et al. (2008) Safety of upper-room ultraviolet germicidal air disinfection for room occupants: results from the Tuberculosis Ultraviolet Shelter Study. Public Health Rep 123: 52-60; Escombe A R, Moore D A, Gilman R H, Navincopa M, Ticona E, et al. (2009) Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med 6: e43), they have not, however, been widely used, in part, because of safety concerns relating to potential low-level broad-spectrum UV exposure. (See, e.g., Nardell E A, Bucher S J, Brickner P W, Wang C, Vincent R L, et al. (2008) Safety of upper-room ultraviolet germicidal air disinfection for room occupants: results from the Tuberculosis Ultraviolet Shelter Study. Public Health Rep 123: 52-60; Wengraitis S, Reed N G (2012) Ultraviolet spectral reflectance of ceiling tiles, and implication for the safe use of upper-room ultraviolet germicidal irradiation. Photochem Photobiol 88: 1480-1488; Sliney D (2013) Balancing the risk of eye irritation from UV-C with infection from bioaerosols. Photochem Photobiol 89: 770-776).
-
FIG. 5 shows an exemplary block diagram of an exemplary embodiment of a system according to the present disclosure. For example, exemplary procedures in accordance with the present disclosure described herein can be performed by or controlled using aUV generation source 580 and/or hardware processing arrangement and/or acomputing arrangement 510, separately and in conjunction with one another. Such exemplary processing/computing arrangement 510 can be, e.g., entirely or a part of, or include, but not limited to, a computer/processor 520 that can include, e.g., one or more microprocessors, and use instructions stored on a computer-accessible medium (e.g., RAM, ROM, hard drive, or other storage device). - As shown in
FIG. 5 , e.g., a computer-accessible medium 530 (e.g., as described herein above, a storage device such as a hard disk, floppy disk, memory stick, CD-ROM, RAM, ROM, etc., or a collection thereof) can be provided (e.g., in communication with the processing arrangement 510). The computer-accessible medium 530 can containexecutable instructions 540 thereon. In addition or alternatively, astorage arrangement 550 can be provided separately from the computer-accessible medium 530, which can provide the instructions to theprocessing arrangement 510 so as to configure the processing arrangement to execute certain exemplary procedures, processes and methods, as described herein above, for example. - Further, the
exemplary processing arrangement 510 can be provided with or include an input/output arrangement 570, which can include, e.g., a wired network, a wireless network, the internet, an intranet, a data collection probe, a sensor, etc. As shown inFIG. 5 , theexemplary processing arrangement 510 can be in communication with anexemplary display arrangement 560, which, according to certain exemplary embodiments of the present disclosure, can be a touch-screen configured for inputting information to the processing arrangement in addition to outputting information from the processing arrangement, for example. Further, theexemplary display 560 and/or astorage arrangement 550 can be used to display and/or store data in a user-accessible format and/or user-readable format. - The foregoing merely illustrates the principles of the disclosure. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements, and procedures which, although not explicitly shown or described herein, embody the principles of the disclosure and can be thus within the spirit and scope of the disclosure. In addition, all publications and references referred to above can be incorporated herein by reference in their entireties. It should be understood that the exemplary procedures described herein can be stored on any computer accessible medium, including a hard drive, RAM, ROM, removable disks, CD-ROM, memory sticks, etc., and executed by a processing arrangement and/or computing arrangement which can be and/or include a hardware processors, microprocessor, mini, macro, mainframe, etc., including a plurality and/or combination thereof In addition, certain terms used in the present disclosure, including the specification, drawings and claims thereof, can be used synonymously in certain instances, including, but not limited to, e.g., data and information. It should be understood that, while these words, and/or other words that can be synonymous to one another, can be used synonymously herein, that there can be instances when such words can be intended to not be used synonymously. Further, to the extent that the prior art knowledge has not been explicitly incorporated by reference herein above, it can be explicitly being incorporated herein in its entirety. All publications referenced can be incorporated herein by reference in their entireties.
Claims (17)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/021,631 US10071262B2 (en) | 2011-03-07 | 2013-09-09 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US14/886,635 US10369379B2 (en) | 2011-03-07 | 2015-10-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/116,593 US10994153B2 (en) | 2011-03-07 | 2018-08-29 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/453,565 US11007380B2 (en) | 2011-03-07 | 2019-06-26 | Apparatus, method and system for selectively effecting and/or killing bacteria |
US16/453,492 US11013934B2 (en) | 2011-03-07 | 2019-06-26 | Apparatus, method and system for selectively effecting and/or killing bacteria |
US16/694,378 US10780189B2 (en) | 2011-03-07 | 2019-11-25 | Apparatus, method and system for selectively affecting and/or killing a virus |
US16/901,728 US11291738B2 (en) | 2011-03-07 | 2020-06-15 | Apparatus, method and system for selectively affecting and/or killing a virus |
US16/942,466 US11007291B2 (en) | 2011-03-07 | 2020-07-29 | Apparatus, method and system for selectively affecting and/or killing a virus |
US17/172,898 US11590359B2 (en) | 2011-03-07 | 2021-02-10 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/177,928 US11607558B2 (en) | 2011-03-07 | 2021-02-17 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/179,006 US11617898B2 (en) | 2011-03-07 | 2021-02-18 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/180,284 US11617899B2 (en) | 2011-03-07 | 2021-02-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/182,601 US11617900B2 (en) | 2011-03-07 | 2021-02-23 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/233,981 US20210236672A1 (en) | 2011-03-07 | 2021-04-19 | Apparatus, method and system for selectively affecting and/or killing a virus |
US17/321,987 US11918828B2 (en) | 2011-03-07 | 2021-05-17 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/521,307 US20220054678A1 (en) | 2011-03-07 | 2021-11-08 | Apparatus, method and system for selectively affecting and/or killing a virus |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161450038P | 2011-03-07 | 2011-03-07 | |
PCT/US2012/027963 WO2012122210A1 (en) | 2011-03-07 | 2012-03-07 | Apparatus, method, and system for selectively affecting and/or killing bacteria |
US14/021,631 US10071262B2 (en) | 2011-03-07 | 2013-09-09 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/027963 Continuation-In-Part WO2012122210A1 (en) | 2011-03-07 | 2012-03-07 | Apparatus, method, and system for selectively affecting and/or killing bacteria |
PCT/US2012/027963 Continuation WO2012122210A1 (en) | 2011-03-07 | 2012-03-07 | Apparatus, method, and system for selectively affecting and/or killing bacteria |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/886,635 Division US10369379B2 (en) | 2011-03-07 | 2015-10-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/116,593 Continuation US10994153B2 (en) | 2011-03-07 | 2018-08-29 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
Publications (3)
Publication Number | Publication Date |
---|---|
US20150073396A1 US20150073396A1 (en) | 2015-03-12 |
US20150265346A9 true US20150265346A9 (en) | 2015-09-24 |
US10071262B2 US10071262B2 (en) | 2018-09-11 |
Family
ID=46798542
Family Applications (11)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/021,631 Active US10071262B2 (en) | 2011-03-07 | 2013-09-09 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US14/886,635 Active US10369379B2 (en) | 2011-03-07 | 2015-10-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/116,593 Active 2032-04-06 US10994153B2 (en) | 2011-03-07 | 2018-08-29 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/453,492 Active 2032-05-11 US11013934B2 (en) | 2011-03-07 | 2019-06-26 | Apparatus, method and system for selectively effecting and/or killing bacteria |
US16/453,565 Active 2032-06-05 US11007380B2 (en) | 2011-03-07 | 2019-06-26 | Apparatus, method and system for selectively effecting and/or killing bacteria |
US17/172,898 Active 2032-06-15 US11590359B2 (en) | 2011-03-07 | 2021-02-10 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/177,928 Active 2032-08-01 US11607558B2 (en) | 2011-03-07 | 2021-02-17 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/179,006 Active 2032-07-29 US11617898B2 (en) | 2011-03-07 | 2021-02-18 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/180,284 Active 2032-08-12 US11617899B2 (en) | 2011-03-07 | 2021-02-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/182,601 Active 2032-08-02 US11617900B2 (en) | 2011-03-07 | 2021-02-23 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/321,987 Active 2032-08-10 US11918828B2 (en) | 2011-03-07 | 2021-05-17 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
Family Applications After (10)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/886,635 Active US10369379B2 (en) | 2011-03-07 | 2015-10-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/116,593 Active 2032-04-06 US10994153B2 (en) | 2011-03-07 | 2018-08-29 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US16/453,492 Active 2032-05-11 US11013934B2 (en) | 2011-03-07 | 2019-06-26 | Apparatus, method and system for selectively effecting and/or killing bacteria |
US16/453,565 Active 2032-06-05 US11007380B2 (en) | 2011-03-07 | 2019-06-26 | Apparatus, method and system for selectively effecting and/or killing bacteria |
US17/172,898 Active 2032-06-15 US11590359B2 (en) | 2011-03-07 | 2021-02-10 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/177,928 Active 2032-08-01 US11607558B2 (en) | 2011-03-07 | 2021-02-17 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/179,006 Active 2032-07-29 US11617898B2 (en) | 2011-03-07 | 2021-02-18 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/180,284 Active 2032-08-12 US11617899B2 (en) | 2011-03-07 | 2021-02-19 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/182,601 Active 2032-08-02 US11617900B2 (en) | 2011-03-07 | 2021-02-23 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
US17/321,987 Active 2032-08-10 US11918828B2 (en) | 2011-03-07 | 2021-05-17 | Apparatus, method, and system for selectively effecting and/or killing bacteria |
Country Status (5)
Country | Link |
---|---|
US (11) | US10071262B2 (en) |
EP (3) | EP3848092A1 (en) |
JP (2) | JP6025756B2 (en) |
DK (1) | DK2683442T3 (en) |
WO (1) | WO2012122210A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11007292B1 (en) | 2020-05-01 | 2021-05-18 | Uv Innovators, Llc | Automatic power compensation in ultraviolet (UV) light emission device, and related methods of use, particularly suited for decontamination |
US11786622B2 (en) | 2020-05-08 | 2023-10-17 | Ultra-Violet Solutions, Llc | Far UV-C light apparatus |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180169279A1 (en) | 2011-03-07 | 2018-06-21 | The Trustees Of Columbia University In The City Of New York | Apparatus, method and system for selectively affecting and/or killing a virus |
EP3848092A1 (en) | 2011-03-07 | 2021-07-14 | The Trustees of Columbia University in the City of New York | Apparatus, method, and system for selectively effecting and/or killing bacteria |
WO2016196904A1 (en) * | 2015-06-03 | 2016-12-08 | The Trustees Of Columbia University In The City Of New York | Apparatus, method and system for selectively affecting and/or killing a virus |
EP3003375B1 (en) * | 2013-06-05 | 2019-11-20 | Farhad Hafezi | Method of applying a composition and pharmaceutical composition with a regimen of administering it |
US9511159B2 (en) | 2014-07-02 | 2016-12-06 | At&T Intellectual Property I, L.P. | Method and apparatus for sterilizing a surface |
CN106794357B (en) * | 2014-09-19 | 2019-02-19 | 夏普株式会社 | Sterilizing unit |
WO2016187145A1 (en) | 2015-05-15 | 2016-11-24 | The Trustees Of Columbia University In The City Of New York | Ultraviolet sleeves for percutaneous devices and methods for using and/or providing the same |
US20160346565A1 (en) * | 2015-05-29 | 2016-12-01 | Nathaniel L.R. Rhodes | Methods and apparatus to deliver therapeutic non-ultraviolet electromagnetic radiation to a body surface |
JP6735225B2 (en) * | 2015-12-25 | 2020-08-05 | 共栄化学工業株式会社 | External skin composition and oral composition |
JP2017136145A (en) * | 2016-02-02 | 2017-08-10 | ウシオ電機株式会社 | Pasteurizer |
CN106345065A (en) * | 2016-08-26 | 2017-01-25 | 何玲 | Infected wound ultraviolet sterilization device |
CN110167605B (en) * | 2017-01-10 | 2021-08-24 | 优志旺电机株式会社 | Ultraviolet sterilization device |
GB2559216B (en) * | 2017-07-17 | 2019-02-06 | Acxel Tech Ltd | An electrowetting on dielectric droplet manipulation device |
JP6493703B1 (en) * | 2017-09-28 | 2019-04-03 | ウシオ電機株式会社 | Sterilization method, sterilizer |
DE102017009637B4 (en) * | 2017-10-17 | 2020-11-26 | Blv Licht- Und Vakuumtechnik Gmbh | Hand dryer with UV disinfection device |
JP6497427B1 (en) * | 2017-10-19 | 2019-04-10 | ウシオ電機株式会社 | Sterilizer |
JP6950522B2 (en) * | 2017-12-27 | 2021-10-13 | ウシオ電機株式会社 | Microorganism inactivation treatment device and cell activation treatment device, and microorganism inactivation treatment method |
JP7182078B2 (en) * | 2019-03-29 | 2022-12-02 | ウシオ電機株式会社 | Sterilization state detection method, sterilization method, sterilization state detection device, sterilization device |
JP7375367B2 (en) * | 2019-08-22 | 2023-11-08 | ウシオ電機株式会社 | Sterilizers and indoor sterilization systems |
US11964062B2 (en) | 2019-09-03 | 2024-04-23 | Luxhygenix Inc. | Antimicrobial device using ultraviolet light |
US20220409755A1 (en) | 2019-10-07 | 2022-12-29 | Ushio Denki Kabushiki Kaisha | Ultraviolet irradiation device |
JP7331708B2 (en) | 2020-01-20 | 2023-08-23 | ウシオ電機株式会社 | UV irradiation device |
US20230130283A1 (en) * | 2020-02-18 | 2023-04-27 | Ushio Denki Kabushiki Kaisha | Bacteriostatic method |
US11801396B1 (en) | 2020-03-10 | 2023-10-31 | Cosmo Haralambidis | Wearable device including UVC light source for reduction in virus and bacteria transmission |
US11298564B2 (en) | 2020-03-10 | 2022-04-12 | Dennis M. Anderson | Medical, surgical and patient lighting apparatus, system, method and controls with pathogen killing electromagnetic radiation |
CN113908307A (en) * | 2020-03-17 | 2022-01-11 | 优志旺电机株式会社 | Inactivation device and inactivation method |
JP2021146178A (en) * | 2020-07-13 | 2021-09-27 | ウシオ電機株式会社 | Inactivation device and inactivation method |
MX2022011984A (en) * | 2020-03-26 | 2023-02-01 | Marigdalia Kaleth Ramirez Fort | Ultraviolet radiation treatments. |
US11614407B2 (en) | 2020-04-20 | 2023-03-28 | Denovo Lighting, Llc | Devices for instant detection and disinfection of aerosol droplet particles using UV light sources |
US11305025B1 (en) * | 2020-04-28 | 2022-04-19 | Robert Barry | Disinfectant apparatus |
US11281027B2 (en) | 2020-05-12 | 2022-03-22 | Everett Ewell Poteet | Eyeglasses and methods of inactivating a virus with ultraviolet light |
US11033060B1 (en) * | 2020-05-19 | 2021-06-15 | Aslan Medical Equipment, Llc | Soft silicone edged cushion for face and oxygen masks with ultraviolet light source |
GB2595468A (en) * | 2020-05-26 | 2021-12-01 | Clemente Angelo | A device |
US20220001062A1 (en) * | 2020-07-02 | 2022-01-06 | Microtek, Inc. | Disinfection of air and surfaces with ultraviolet light |
EP3939653A1 (en) * | 2020-07-13 | 2022-01-19 | GME German Medical Engineering GmbH | Germicidal uv irradiation apparatus |
CH717662A1 (en) * | 2020-07-15 | 2022-01-31 | Jk Holding Gmbh | Device for physical relaxation of a human being, use of a light source and method for disinfecting the device. |
JP6949394B1 (en) * | 2020-07-16 | 2021-10-13 | 株式会社吉田製作所 | Medical equipment |
JP2022024467A (en) * | 2020-07-28 | 2022-02-09 | ミネベアミツミ株式会社 | Sterilizer |
JP6948605B1 (en) | 2020-08-05 | 2021-10-13 | ウシオ電機株式会社 | Bacterial or virus inactivating method, bacterial or virus inactivating device |
CN116133697A (en) * | 2020-08-05 | 2023-05-16 | 优志旺电机株式会社 | Device for inactivating fungus or virus and method for inactivating fungus or virus |
JP7099500B2 (en) * | 2020-08-25 | 2022-07-12 | ウシオ電機株式会社 | Inactivating device and inactivating method |
JP7507033B2 (en) | 2020-08-07 | 2024-06-27 | ホーチキ株式会社 | Facility Management System |
US11752228B2 (en) | 2020-08-24 | 2023-09-12 | Lumenlabs Llc | Highly efficient UV C bulb with multifaceted filter |
US20220059338A1 (en) | 2020-08-24 | 2022-02-24 | Sportsbeams Lighting, Inc. | Cartridge based uv c sterilization system |
JP2022041670A (en) * | 2020-09-01 | 2022-03-11 | ウシオ電機株式会社 | Low insect-attracting method for inactivating bacteria or virus |
JP6947261B1 (en) | 2020-09-01 | 2021-10-13 | ウシオ電機株式会社 | Ultraviolet irradiation device |
JP2022041627A (en) * | 2020-09-01 | 2022-03-11 | ウシオ電機株式会社 | Light source device |
US20220072186A1 (en) * | 2020-09-09 | 2022-03-10 | Aleddra Inc. | Disinfecting Circadian Lighting Device |
JP7237902B2 (en) | 2020-09-14 | 2023-03-13 | ミネベアミツミ株式会社 | Sterilization system, sterilization device, control device, control method and control program |
JP7237901B2 (en) | 2020-09-14 | 2023-03-13 | ミネベアミツミ株式会社 | Sterilization system, sterilization device, control device, control method and control program |
JP7303787B2 (en) | 2020-09-14 | 2023-07-05 | ミネベアミツミ株式会社 | Sterilization system, sterilization device, control device, control method and control program |
JP2022062580A (en) * | 2020-10-08 | 2022-04-20 | ウシオ電機株式会社 | Ultraviolet light irradiation device, and method for use of ultraviolet light irradiation device |
CN114630686A (en) * | 2020-10-08 | 2022-06-14 | 优志旺电机株式会社 | Ultraviolet irradiation apparatus, method of using ultraviolet irradiation apparatus, and method of irradiating ultraviolet light |
KR102427239B1 (en) * | 2020-10-22 | 2022-08-22 | (주)아덴하이진 | sterilization device using UV light source harmless to human body |
JP6977898B1 (en) | 2020-12-01 | 2021-12-08 | ウシオ電機株式会社 | UV irradiation device and UV irradiation method |
JPWO2022137920A1 (en) * | 2020-12-23 | 2022-06-30 | ||
US11439840B2 (en) | 2021-01-21 | 2022-09-13 | Joseph McQuirter, SR. | Far ultraviolet light application device |
JP2022112565A (en) | 2021-01-22 | 2022-08-03 | ウシオ電機株式会社 | Protection processing method, inactivation function mounting method, sheet material, and structure |
JP7491237B2 (en) | 2021-02-17 | 2024-05-28 | ウシオ電機株式会社 | Method for inactivating bacteria or viruses |
US20240226347A9 (en) | 2021-02-24 | 2024-07-11 | Nobuhiro UMEMURA | 215- to 222-nm wavelength laser light generating device |
US20220266057A1 (en) * | 2021-02-25 | 2022-08-25 | John William Thompson | Touchless-switch skin sanitizing system-uvc far light |
US11313726B1 (en) | 2021-03-23 | 2022-04-26 | Lumenlabs Llc | Safe UV-C dosimeter |
WO2022220157A1 (en) * | 2021-04-14 | 2022-10-20 | ウシオ電機株式会社 | Ultraviolet light irradiation device |
JP2022170838A (en) * | 2021-04-30 | 2022-11-11 | ウシオ電機株式会社 | Ultraviolet detector |
JP7015485B1 (en) * | 2021-04-30 | 2022-02-03 | ウシオ電機株式会社 | Ultraviolet light irradiation device, how to use the ultraviolet light irradiation device, and how to irradiate ultraviolet light |
US11224675B1 (en) * | 2021-06-21 | 2022-01-18 | Akcasu Airborne Virus Protection Systems, Inc. | Ultraviolet-C (UV-C) mercury discharge tube irradiated forced airflow face shield |
JP2023014717A (en) * | 2021-07-19 | 2023-01-31 | ウシオ電機株式会社 | Inactivating method and inactivating device |
WO2023053820A1 (en) * | 2021-09-29 | 2023-04-06 | ウシオ電機株式会社 | Method for sterilizing antibacterial resin molded article, method for maintaining antibacterial resin molded article, and method for maintaining toilet seat molded using antibacterial resin |
JP2023074719A (en) | 2021-11-18 | 2023-05-30 | ウシオ電機株式会社 | Inactivation device, optical filter |
WO2023092109A1 (en) * | 2021-11-20 | 2023-05-25 | Lunman Kyler F Ii | Method for environmentally-modifying air within and indoor space |
JP2023119620A (en) | 2022-02-17 | 2023-08-29 | ウシオ電機株式会社 | Inactivation method and inactivation system |
JP2023125954A (en) | 2022-02-28 | 2023-09-07 | ウシオ電機株式会社 | Light source device |
WO2023217824A1 (en) | 2022-05-12 | 2023-11-16 | Signify Holding B.V. | Disinfection lamp with reflector |
US11929248B1 (en) | 2023-05-22 | 2024-03-12 | City University Of Hong Kong | Far-UVC light source with an internal dielectric coating filter arranged on the interior side of electrode |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6730113B2 (en) * | 2001-06-15 | 2004-05-04 | Uv-Solutions Llc | Method and apparatus for sterilizing or disinfecting a region through a bandage |
US20050256554A1 (en) * | 2003-12-23 | 2005-11-17 | American Environmental Systems, Inc | LED multiplex source and method of use of for sterilization, bioactivation and therapy |
US20050261751A1 (en) * | 2002-07-11 | 2005-11-24 | Thomas Justel | Tanning device |
US20090036953A1 (en) * | 2007-08-02 | 2009-02-05 | Morgan Lars Ake Gustavsson | Device and method for treatment of organic tissue |
US8089057B2 (en) * | 2003-11-03 | 2012-01-03 | Spectrometrix Optoelectronic Systems Gmbh | Radiation converter and irradiation arrangement containing said converter |
US20130085385A1 (en) * | 2011-05-23 | 2013-04-04 | George A. Luiken | Surgical lighting sources for use with fluophore-tagged monoclonal antibodies or fluorophore-tagged tumor avid compounds |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE566288C (en) * | 1927-09-06 | 1932-12-14 | Siemens & Halske Akt Ges | Device for the treatment of living cells by means of light rays |
US1858968A (en) | 1930-07-08 | 1932-05-17 | Pioch Walter | Means for hanging up hats |
US4254339A (en) * | 1977-06-29 | 1981-03-03 | Yanagimoto Seisakusho Co. Ltd. | Method for the fluorimetric quantitative determination of SO2 in gases and apparatus therefor |
US4408825A (en) * | 1980-11-10 | 1983-10-11 | Acton Research Corporation | Vacuum ultraviolet reflectance filter |
NL8502534A (en) * | 1985-09-17 | 1987-04-16 | Philips Nv | RADIATION DEVICE. |
AU597289B2 (en) * | 1985-10-09 | 1990-05-31 | Commonwealth Scientific And Industrial Research Organisation | Phototherapy of skin wounds |
US4950456A (en) * | 1987-02-27 | 1990-08-21 | Shell Oil Company | Apparatus for analysis of a sample for sulphur |
JPH0794383A (en) * | 1993-08-05 | 1995-04-07 | Ushio Inc | Image forming method |
US5776174A (en) * | 1995-01-30 | 1998-07-07 | Illumenex Corporation | Stabilization of vascular lesions by ultraviolet radiation |
US5814516A (en) * | 1995-10-13 | 1998-09-29 | Lockheed Martin Energy Systems, Inc. | Surface enhanced Raman gene probe and methods thereof |
US5871522A (en) * | 1996-10-28 | 1999-02-16 | Senasco, Inc. | Apparatus and method for projecting germicidal ultraviolet radiation |
US6264802B1 (en) * | 1997-06-23 | 2001-07-24 | Alexandr Semenovich Kamrukov | Method and device for UV treatment of liquids, air and surfaces |
US5936250A (en) * | 1997-07-24 | 1999-08-10 | General Monitors, Incorporated | Ultraviolet toxic gas point detector |
AU753047B2 (en) * | 1997-11-14 | 2002-10-03 | Ethicon Inc. | Method for measuring the concentration of hydrogen peroxide vapor |
JP2000135800A (en) | 1998-08-28 | 2000-05-16 | Hitachi Koki Co Ltd | Method for driving on-demand type multinozzle ink jet head |
US6376972B1 (en) * | 1998-11-19 | 2002-04-23 | The United States Of America As Represented By The United States Department Of Energy | Powerful glow discharge excilamp |
JP2000212554A (en) | 1998-11-20 | 2000-08-02 | Idemitsu Kosan Co Ltd | Fluorescence conversion medium and display device using the same |
US7879288B2 (en) * | 1999-03-01 | 2011-02-01 | Johnson & Johnson Vision Care, Inc. | Method and apparatus of sterilization using monochromatic UV radiation source |
US6464625B2 (en) * | 1999-06-23 | 2002-10-15 | Robert A. Ganz | Therapeutic method and apparatus for debilitating or killing microorganisms within the body |
US6429438B1 (en) * | 1999-07-12 | 2002-08-06 | Waterhealth International, Inc. | Ultraviolet light detector for liquid disinfection unit |
GB2367495B (en) | 1999-07-19 | 2004-06-16 | Mitsui Shipbuilding Eng | Method and apparatus for purifying oxygen containing gas |
US6638307B2 (en) * | 1999-12-29 | 2003-10-28 | Igor Valyunin | Methods of surface treatment for enhancing the performance of a floating phakic refractive lens design |
US6766097B2 (en) * | 2000-11-28 | 2004-07-20 | Remote Light, Inc. | UV portal-based appliances and containers |
US20030023284A1 (en) | 2001-02-20 | 2003-01-30 | Vladimir Gartstein | Method and apparatus for the in-vivo treatment of pathogens |
WO2003002186A2 (en) * | 2001-06-26 | 2003-01-09 | Photomed Technologies, Inc. | Therapeutic methods using electromagnetic radiation |
US20040158300A1 (en) * | 2001-06-26 | 2004-08-12 | Allan Gardiner | Multiple wavelength illuminator having multiple clocked sources |
US6597003B2 (en) * | 2001-07-12 | 2003-07-22 | Axcelis Technologies, Inc. | Tunable radiation source providing a VUV wavelength planar illumination pattern for processing semiconductor wafers |
US20030051990A1 (en) * | 2001-08-15 | 2003-03-20 | Crt Holdings, Inc. | System, method, and apparatus for an intense ultraviolet radiation source |
US7704272B2 (en) * | 2002-01-31 | 2010-04-27 | University Of Rochester | Method for introducing an ultraviolet light activated viral vector into the spinal column |
US6581441B1 (en) * | 2002-02-01 | 2003-06-24 | Perseptive Biosystems, Inc. | Capillary column chromatography process and system |
US6960201B2 (en) * | 2002-02-11 | 2005-11-01 | Quanticum, Llc | Method for the prevention and treatment of skin and nail infections |
US8808268B2 (en) * | 2002-02-14 | 2014-08-19 | Gholam A. Peyman | Method and composition for hyperthermally treating cells |
US7409954B2 (en) * | 2002-08-09 | 2008-08-12 | Genestho Inc. | Method for treatment of infections with ultraviolet laser light |
JP4009969B2 (en) * | 2002-12-10 | 2007-11-21 | 株式会社ニコン | Ultraviolet light source, phototherapy device, exposure device, and test object inspection device |
US7268355B2 (en) | 2002-12-27 | 2007-09-11 | Franek Olstowski | Excimer UV fluorescence detection |
DE10316487B4 (en) * | 2003-04-09 | 2005-03-31 | Heraeus Tenevo Ag | Process for producing a preform for optical fibers |
US20040200975A1 (en) * | 2003-04-14 | 2004-10-14 | Brown Dale Marius | Ultraviolet sensors for monitoring energy in the germicidal wavelengths |
US6909512B1 (en) * | 2003-05-30 | 2005-06-21 | Lockheed Martin Corporation | Method and apparatus for estimating piston using a grism |
JP2005055508A (en) * | 2003-08-05 | 2005-03-03 | Fujikura Ltd | Method and device for manufacturing grating type optical components, and optical components produced using the method and device |
US20050074779A1 (en) * | 2003-10-02 | 2005-04-07 | Tuan Vo-Dinh | SERS molecular probe for diagnostics and therapy |
CN1914126B (en) * | 2003-12-12 | 2010-09-29 | 六号元素有限公司 | Method of incorporating a mark in CVD diamond |
US7485883B2 (en) * | 2003-12-19 | 2009-02-03 | Gardner Iii William G | Variable wavelength radiation source |
EP1735054A4 (en) * | 2004-03-09 | 2010-01-20 | Ledeep Llc | Phototherapy systems and methods |
US7201767B2 (en) * | 2004-05-27 | 2007-04-10 | Bhullar Tarseam S | Device for ultraviolet radiation treatment of body tissues |
JP2006040867A (en) * | 2004-06-23 | 2006-02-09 | Hoya Candeo Optronics株式会社 | Excimer lamp apparatus |
US7738096B2 (en) * | 2004-10-21 | 2010-06-15 | University Of Georgia Research Foundation, Inc. | Surface enhanced Raman spectroscopy (SERS) systems, substrates, fabrication thereof, and methods of use thereof |
WO2006058062A2 (en) * | 2004-11-22 | 2006-06-01 | Energex Systems, Inc. | Blood irradiation system, associated devices and methods for irradiating blood |
US8109981B2 (en) * | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
CN101238363A (en) * | 2005-01-31 | 2008-08-06 | S·E·内斯特尔 | Method and apparatus for sterilizing and disinfecting air and surfaces and protecting a zone from external microbial contamination |
WO2007000388A1 (en) * | 2005-06-29 | 2007-01-04 | Sk Technologies Gmbh | Medical device and method |
FR2890747B1 (en) * | 2005-09-15 | 2008-05-09 | Flowgene Sa | METHOD AND DEVICE FOR ANALYZING CHEMICAL COMPOUNDS |
US20070135874A1 (en) * | 2005-11-22 | 2007-06-14 | Bala John L | Endoscope for therapeutic light delivery |
JP4687436B2 (en) | 2005-12-13 | 2011-05-25 | ウシオ電機株式会社 | Excimer light therapy device |
US20070189018A1 (en) * | 2006-02-16 | 2007-08-16 | Delaware Capital Formation, Inc. | Curing system and method of curing |
US20070219600A1 (en) * | 2006-03-17 | 2007-09-20 | Michael Gertner | Devices and methods for targeted nasal phototherapy |
US20140012224A1 (en) * | 2006-04-07 | 2014-01-09 | The Regents Of The University Of California | Targeted hollow gold nanostructures and methods of use |
US20090263485A1 (en) * | 2008-03-01 | 2009-10-22 | Chun Li | Targeted hollow gold nanostructures and methods of use |
US7372044B2 (en) | 2006-05-17 | 2008-05-13 | Andrew Ross | UV sterilization of user interface fomites |
FR2906035B1 (en) * | 2006-09-15 | 2008-11-28 | Commissariat Energie Atomique | METHOD OF QUANTITATIVE MEASUREMENT OF BIOMOLECULE TARGETS DEPOSITED ON A BIOPUCE, AND DEVICE FOR IMPLEMENTING IT. |
US20080096097A1 (en) * | 2006-10-16 | 2008-04-24 | Narsingh Bahadur Singh | Novel narrowband crystal UV filters |
WO2008067361A2 (en) * | 2006-11-28 | 2008-06-05 | Valam Corporation | Method and system for controlling the spread of microorganisms among subjects in a group |
EP2134642B1 (en) * | 2007-04-02 | 2016-02-24 | Emory University | SERS nanoparticle tags and method for spectroscopic detection of tumors |
US8795628B2 (en) * | 2007-05-04 | 2014-08-05 | The Board Of Trustees Of The Leland Stanford Junior University | Molecular imaging of living subjects using Raman spectroscopy and labeled Raman nanoparticles |
US20090143842A1 (en) * | 2007-11-02 | 2009-06-04 | Cumbie William E | Phototherapy Treatment and Device for Infections, Diseases, and Disorders |
US8523847B2 (en) * | 2007-11-07 | 2013-09-03 | Reliant Technologies, Inc. | Reconnectable handpieces for optical energy based devices and methods for adjusting device components |
US8378324B2 (en) * | 2008-02-07 | 2013-02-19 | William G. Gardner, III | Handheld portable multi purpose sterilizing wavelength transforming converter |
WO2009149020A1 (en) * | 2008-06-04 | 2009-12-10 | Triton Thalassic Technologies, Inc. | Methods, systems and apparatus for monochromatic uv light sterilization |
US20100222852A1 (en) * | 2009-02-24 | 2010-09-02 | Vasily David B | Apparatus and Method for Decolonizing Microbes on the Surfaces of the Skin and In Body Cavities |
JP2010276486A (en) * | 2009-05-29 | 2010-12-09 | Mitsubishi Chemical Analytech Co Ltd | Sulphur analysis method and analyzer |
US20110054574A1 (en) | 2009-08-26 | 2011-03-03 | Perry Felix | Ultraviolet sterilizer for surgery |
US9282620B2 (en) * | 2009-09-11 | 2016-03-08 | Lutronic Corporation | Apparatus and method for generating constant current pulse wave, medical operation method using same, and light generating apparatus |
US8322191B2 (en) * | 2010-06-30 | 2012-12-04 | Honeywell International Inc. | Enhanced cavity for a photoacoustic gas sensor |
DE102010034626A1 (en) * | 2010-08-17 | 2012-02-23 | B. Braun Avitum Ag | Device for extracorporeal blood treatment |
CN103168274B (en) * | 2010-10-21 | 2016-07-06 | 日产化学工业株式会社 | EUV lithography resistant upper layer film formation compositions |
US9345389B2 (en) * | 2010-11-12 | 2016-05-24 | Emory University | Additional systems and methods for providing real-time anatomical guidance in a diagnostic or therapeutic procedure |
US8981314B2 (en) * | 2011-02-10 | 2015-03-17 | Zaps Technologies, Inc | Method and apparatus for the optical determination of total organic carbon in aqueous streams |
US20180169279A1 (en) * | 2011-03-07 | 2018-06-21 | The Trustees Of Columbia University In The City Of New York | Apparatus, method and system for selectively affecting and/or killing a virus |
EP3848092A1 (en) | 2011-03-07 | 2021-07-14 | The Trustees of Columbia University in the City of New York | Apparatus, method, and system for selectively effecting and/or killing bacteria |
DE102011102687A1 (en) * | 2011-05-20 | 2012-11-22 | XYLEM IP Holding LLC | Control for a UV disinfection system with broadband UV lamps |
US9093258B2 (en) * | 2011-06-08 | 2015-07-28 | Xenex Disinfection Services, Llc | Ultraviolet discharge lamp apparatuses having optical filters which attenuate visible light |
US20140316255A1 (en) * | 2011-09-02 | 2014-10-23 | Ellis Garai | Raman Imaging Devices and Methods of Molecular Imaging |
US9561292B1 (en) * | 2012-08-20 | 2017-02-07 | Duke University | Nanostars and nanoconstructs for detection, imaging, and therapy |
GB201219487D0 (en) * | 2012-10-30 | 2012-12-12 | Cancer Rec Tech Ltd | Anti-S100A4 antibody molecules and their uses |
CA2837770A1 (en) | 2013-12-30 | 2015-06-30 | Quang Qt To | Dry hand sanitizer |
US9671351B2 (en) * | 2014-04-24 | 2017-06-06 | Stmicroelectronics S.R.L. | Multi-sensor optical device for detecting chemical species and manufacturing method thereof |
WO2016015010A1 (en) * | 2014-07-25 | 2016-01-28 | Amo Manufacturing Usa, Llc | Systems and methods for laser beam direct measurement and error budget |
CN106794357B (en) * | 2014-09-19 | 2019-02-19 | 夏普株式会社 | Sterilizing unit |
JP6950522B2 (en) * | 2017-12-27 | 2021-10-13 | ウシオ電機株式会社 | Microorganism inactivation treatment device and cell activation treatment device, and microorganism inactivation treatment method |
-
2012
- 2012-03-07 EP EP21160484.8A patent/EP3848092A1/en active Pending
- 2012-03-07 EP EP21160473.1A patent/EP3848091A1/en active Pending
- 2012-03-07 WO PCT/US2012/027963 patent/WO2012122210A1/en active Application Filing
- 2012-03-07 DK DK12755325.3T patent/DK2683442T3/en active
- 2012-03-07 EP EP12755325.3A patent/EP2683442B1/en active Active
- 2012-03-07 JP JP2013557814A patent/JP6025756B2/en active Active
-
2013
- 2013-09-09 US US14/021,631 patent/US10071262B2/en active Active
-
2015
- 2015-10-19 US US14/886,635 patent/US10369379B2/en active Active
-
2016
- 2016-06-28 JP JP2016127873A patent/JP6306097B2/en active Active
-
2018
- 2018-08-29 US US16/116,593 patent/US10994153B2/en active Active
-
2019
- 2019-06-26 US US16/453,492 patent/US11013934B2/en active Active
- 2019-06-26 US US16/453,565 patent/US11007380B2/en active Active
-
2021
- 2021-02-10 US US17/172,898 patent/US11590359B2/en active Active
- 2021-02-17 US US17/177,928 patent/US11607558B2/en active Active
- 2021-02-18 US US17/179,006 patent/US11617898B2/en active Active
- 2021-02-19 US US17/180,284 patent/US11617899B2/en active Active
- 2021-02-23 US US17/182,601 patent/US11617900B2/en active Active
- 2021-05-17 US US17/321,987 patent/US11918828B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6730113B2 (en) * | 2001-06-15 | 2004-05-04 | Uv-Solutions Llc | Method and apparatus for sterilizing or disinfecting a region through a bandage |
US20050261751A1 (en) * | 2002-07-11 | 2005-11-24 | Thomas Justel | Tanning device |
US8089057B2 (en) * | 2003-11-03 | 2012-01-03 | Spectrometrix Optoelectronic Systems Gmbh | Radiation converter and irradiation arrangement containing said converter |
US20050256554A1 (en) * | 2003-12-23 | 2005-11-17 | American Environmental Systems, Inc | LED multiplex source and method of use of for sterilization, bioactivation and therapy |
US20090036953A1 (en) * | 2007-08-02 | 2009-02-05 | Morgan Lars Ake Gustavsson | Device and method for treatment of organic tissue |
US20130085385A1 (en) * | 2011-05-23 | 2013-04-04 | George A. Luiken | Surgical lighting sources for use with fluophore-tagged monoclonal antibodies or fluorophore-tagged tumor avid compounds |
Non-Patent Citations (6)
Title |
---|
Lomaev et al., Vacuum-ultraviolet excilamps with excitation by a barrier corona discharge, J. Opt. Technol. 79 (8), August 2012 * |
Mizunami et al., Buffer gas effect in a dischargeâpumped XeBr excimer laser, Journal of Applied Physics 71, 2036 (1992) * |
Panchenko et al., Planar excilamp on rare gas chlorides pumped by a transverse self-sustained discharge, Quantum Electronics 36 (2) 169-173 (2006) * |
Sosnin et al., Bactericidal Iodine Lamp Excited by Capacitive Discharge, Technical Physics Letters, Vol. 30, No. 7, 2004, pp. 615-617 * |
Sosnin et al., Capacitive discharge exciplex lamps, J. Phys. D: Appl. Phys. 38 (2005) 3194-3201 * |
The Chambers Dictionary, definition of "any", 2015 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11007292B1 (en) | 2020-05-01 | 2021-05-18 | Uv Innovators, Llc | Automatic power compensation in ultraviolet (UV) light emission device, and related methods of use, particularly suited for decontamination |
US11020502B1 (en) | 2020-05-01 | 2021-06-01 | Uv Innovators, Llc | Ultraviolet (UV) light emission device, and related methods of use, particularly suited for decontamination |
US11116858B1 (en) | 2020-05-01 | 2021-09-14 | Uv Innovators, Llc | Ultraviolet (UV) light emission device employing visible light for target distance guidance, and related methods of use, particularly suited for decontamination |
US11565012B2 (en) | 2020-05-01 | 2023-01-31 | Uv Innovators, Llc | Ultraviolet (UV) light emission device employing visible light for target distance guidance, and related methods of use, particularly suited for decontamination |
US11883549B2 (en) | 2020-05-01 | 2024-01-30 | Uv Innovators, Llc | Ultraviolet (UV) light emission device employing visible light for operation guidance, and related methods of use, particularly suited for decontamination |
US11786622B2 (en) | 2020-05-08 | 2023-10-17 | Ultra-Violet Solutions, Llc | Far UV-C light apparatus |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11918828B2 (en) | Apparatus, method, and system for selectively effecting and/or killing bacteria | |
US11167051B2 (en) | Apparatus, method and system for selectively affecting and/or killing a virus | |
US11007291B2 (en) | Apparatus, method and system for selectively affecting and/or killing a virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE TRUSTEES OF COMUMBIA UNIVERSITY IN THE CITY OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RANDERS-PEHRSON, GERHARD;BRENNER, DAVID JONATHAN;BIGELOW, ALAN;SIGNING DATES FROM 20131031 TO 20131109;REEL/FRAME:031619/0753 |
|
AS | Assignment |
Owner name: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE TYPOGRAPHICAL ERROR IN THE ASSIGNEE'S NAME PREVIOUSLY RECORDED ON REEL 031619 FRAME 0753. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE'S NAME SHOULD BE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK;ASSIGNORS:RANDERS-PEHRSON, GERHARD;BRENNER, DAVID JONATHAN;BIGELOW, ALAN;SIGNING DATES FROM 20131031 TO 20131109;REEL/FRAME:031752/0562 |
|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |